The pooled analysis yielded a significant difference in GSTP1 hypermethylation between liver cancer tissue and liver tissue from patients with other diseases, with a combined OR of 6.64 (95% CI: 2.17–20.37), indicating that GSTP1 hypermethylation is more frequently observed in liver cancer tissue. Here, GSTP1 is linked to liver cancer.